Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 05/7/18 → 04/9/21 |
Funding
- Neurocrine Biosciences Incorporated: $43,281.51
A Phase 2, Double-Blind, placebo controlled, randomized withdrawal study to evaluate the safety and efficacy of NBI-98854 in pediatric subjects with tourette syndrome
- Swain, James (PI)
- Crowell, Judith (CoPI)
- Parsey, Ramin (CoPI)
Project: Research